Selective synthesis of ent-15-epi-F2t-isoprostane and a deuterated derivative

Synthesis

Volumn , Issue 15, 2007, Pages 2397-2403

  Shizuka, Manami ^a   Snapper, Marc L ^a  

^a BOSTON COLLEGE   (United States)

Author keywords

Asymmetric synthesis; Lipids; Metathesis; Olefination

Indexed keywords

ASYMMETRIC SYNTHESIS; METATHESIS; OLEFINATION;

ISOMERS; LIPIDS; PHYSIOLOGY; STEREOSELECTIVITY; SYNTHESIS (CHEMICAL);

METABOLITES;

ALKENE; ENT 15 EPI F2T ISOPROSTANE; ISOPROSTANE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; ASYMMETRIC SYNTHESIS; CHEMICAL STRESS; ENANTIOMER; ENANTIOSELECTIVITY; ISOMER; OXIDATIVE STRESS; RING OPENING; STEREOCHEMISTRY;

EID: 34547805568     PISSN: 00397881     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-983768     Document Type: Article

References (68)

1. For free radical peroxidation of arachidonic acid, see: (a) Morrow, J. D.; Hill, K. E.; Burk, R. F.; Nammour, T. M.; Badr, K. F.; Roberts, L. J. II Proc. Nat. Acad. Sci. U.S.A. 1990, 87, 9383.
2. (b) Morrow, J. D.; Awad, J. A.; Boss, H. J.; Blair, I. A.; Roberts, L. J. II Proc. Natl. Acad. Sci. U.S.A. 1992, 89, 10721.
3. (c) Morrow, J. D.; Minton, T. A.; Mukundan, C. R.; Campbell, M. D.; Zackert, W. E.; Daniel, V. C.; Badr, K. F.; Blair, I. A.; Roberts, L. J. II J. Biol. Chem. 1994, 269, 4317.
4. (d) Harrison, K. A.; Murphy, R. C. J. Biol. Chem. 1995, 270, 17273.
5. (e) Morrow, J. D.; Awad, J. A.; Wu, A.; Zackert, W. E.; Daniel, V. C.; Roberts, L. J. II J. Biol. Chem. 1996, 271, 23185.
6. (f) Basu, S. Prostaglandins, Leukotrienes Essent. Fatty Acids 1998, 58, 319.
7. (g) Roberts, L. J.; Fessel, J. P. Chem. Phys. Lipids 2004, 128, 173.
8. (h) See also: Wang, D.; DuBois, R. N. Proc. Natl. Acad. Sci. U.S.A. 2004, 101, 415.
9. (a) Natarajan, R.; Lanting, L.; Gonzales, N.; Nadler, J. Am. J. Physiol. 1996, 271, E159.
10. (b) Kunapuli, P.; Lawson, J. A.; Rokach, J. A.; Meinkoth, J. L.; FitzGerald, G. A. J. Biol. Chem. 1998, 273, 22442.
11. (a) Leitinger, N.; Blazek, I.; Sinzinger, H. Thrombosis Res. 1997, 86, 337.
12. (b) Cranshaw, J. H.; Evans, T. W.; Mitchell, J. A. Brit. J. Pharm. 2001, 132, 1699.
13. (c) For review, see: Csiszar, A.; Stef, G.; Pacher, P.; Ungvari, Z. Prostaglandins, Leukotrienes Essent. Fatty Acids 2002, 66, 557.
14. (a) Morrow, J. D.; Zackert, W. E.; Van Der Ende, D. S.; Reich, E. E.; Terry, E. S.; Cox, B.; Sanchez, S. C.; Montine, T. J.; Roberts, L. J. Oxidative Stress Disease 2002, 8, 57.
15. (b) For a recent review, see: Milne, G. L.; Morrow, J. D. Antioxid. Redox Signal. 2006, 8, 1379.
16. (c) Yin, H.; Musiek, E. S.; Morrow, J. D. J. Biol. Sci. 2006, 6, 469.
17. (d) Morrow, J. D. Curr. Pharmaceut. Design 2006, 12, 895.
18. (a) Quinn, J. F.; Montine, K. S.; Moore, M.; Morrow, J. D.; Kaye, J. A.; Montine, T. J. J. Alzheimer's Dis. 2004, 6, 93.
19. (b) Nishio, T.; Miyadera, R.; Sakai, R.; Abe, K.; Kanazawa, H.; Fukui, K.; Urano, S. J. Clin. Biochem. Nutr. 2006, 38, 161.
20. (c) For a review, see: Montine, T. J.; Quinn, J. F.; Kaye, J. A.; Morrow, J. D. Oxidative Stress Disease 2006, 22, 147.
21. (a) For recent review, see: Giovanni, D.; Falco, A.; Patrono, C. Chem. Phys. Lipids 2004, 128, 149.
22. (b) See also: Boyne, M. S.; Sargeant, L. A.; Bennett, F. I.; Wilks, R. J.; Cooper, R. S.; Forrester, T. E. Diabetes Res. Clin. Pract. 2007, 76, 149.
23. (a) Camphausen, K.; Menard, C.; Sproull, M.; Goley, E.; Basu, S.; Coleman, C. N. Int. J. Radiat. Oncol. Biol. Phys. 2004, 58, 1536.
24. (b) Rossner, P. Jr.; Gammon, M. D.; Terry, M. B.; Agrawal, M.; Zhang, F. F.; Teitelbaum, S. L.; Eng, S. M.; Gaudet, M. M.; Neugut, A. I.; Santella, R. M. Cancer Epidem. Biomar. 2006, 15, 639.
25. For reviews, see: (a) Taber, D. F.; Hoerner, S. R.; Herr, J. R.; Gleave, M. D.; Kanai, K.; Pina, R.; Jiang, Q.; Xu, M. Chem. Phys. Lipids 2004, 128, 57.
26. (b) Quan, L. G.; Cha, J. K. Chem. Phys. Lipids 2004, 128, 3.
27. (c) Rokach, J.; Kim, S.; Bellone, S.; Lawson, J. A.; Pratico, D.; Powell, W. S.; FitzGerald, G. A. Chem. Phys. Lipids 2004, 128, 35.
28. For early references, see: (d) Corey, E. J.; Shih, N. Y.; Shimoji, K. Tetrahedron Lett. 1984, 25, 5013.
29. (e) O'Connor, D. E.; Mihelich, E. D.; Coleman, M. C. J. Am. Chem. Soc. 1984, 106, 3577.
30. (f) Rondot, B.; Durand, T.; Girard, J. P.; Rossi, J. C.; Schio, E.; Khanapure, S. P.; Rokach, J. Tetrahedron Lett. 1993, 34, 8245.
31. (g) Hwang, S. W.; Adiyama, M.; Khanapure, S.; Schio, L.; Rokach, J. J. Am. Chem. Soc. 1994, 116, 10829.
32. (h) Larock, R. C.; Lee, N. H. J. Am. Chem. Soc. 1991, 113, 7815.
33. (i) See also: Roland, A.; Durand, T.; Egron, D.; Vidal, J. P.; Rossi, J. C. J. Chem. Soc., Perkin Trans. 1 2000, 245.
34. (j) Durand, T.; Guy, A.; Vidal, J. P.; Rossi, J. C. J. Org. Chem. 2002, 67, 3615.
35. (k) Jacobo, S. H.; Chang, C.-T.; Eee, G.-J.; Lawson, J. A.; Powell, W. S.; Pratico, D.; FitzGerald, G. A.; Rokach, J. J. Org. Chem. 2006, 71, 1370.
36. (l) Jung, M. E.; Berliner, A.; Angst, D.; Yue, D.; Koroniak, L.; Watson, A. D.; Li, R. Org. Lett. 2005, 7, 3933.
37. (m) Pinot, E.; Guy, A.; Guyon, A.-L.; Rossi, J.-C.; Durand, T. Tetrahedron: Asymmetry 2005, 16, 1893.
38. Schrader, T. O.; Snapper, M. L. J. Am. Chem. Soc. 2002, 124, 10998.
39. (a) Schrader, T. O.; Snapper, M. L. Tetrahedron Lett. 2000, 41, 9685.
40. For earlier studies on ring-opening cross-metathesis of cyclobutenes, see: (b) Randall, M. L.; Tallarico, J. A.; Snapper, M. L. J. Am. Chem. Soc. 1995, 117, 9610.
41. (c) Tallarico, J. A.; Bonitatebus, P. J. Jr.; Snapper, M. L. J. Am. Chem. Soc. 1997, 119, 7157.
42. (d) Snapper, M. L.; Tallarico, J. A.; Randall, M. L. J. Am. Chem. Soc. 1997, 119, 1478.
43. (e) Tallarico, J. A.; Randall, M. L.; Snapper, M. L. Tetrahedron 1997, 53, 16511.
44. Schrader, T. O. Ph.D. Thesis; Boston College: Chestnut Hill Massachusetts, 2002.
45. Theil, F.; Schick, H.; Winter, G.; Reck, G. Tetrahedron 1991, 47, 7569.
46. Gosh, A. K.; Liu, W. J. Org. Chem. 1997, 62, 7908.
47. For a more recent and convenient approach to this intermediate, see: Zhao, Y.; Rodrigo, J.; Hoveyda, A. H.; Snapper, M. L. Nature (London) 2006, 443, 67.
48. (a) Buchi, G.; Burgess, E. M. J. Am. Chem. Soc. 1960, 82, 4333.
49. (b) Eaton, P. E. Tetrahedron Lett. 1964, 3695.
50. (c) Serebryakov, E. P.; Kulomzina-Pletneva, S. D.; Margaryan, A. K. Tetrahedron 1979, 35, 77.
51. Cho, J. H.; Kim, B. M. Org. Lett. 2003, 5, 531.
52. Regioselectivity was determined by COSY NMR.
53. Corey, E. J.; Helal, C. J. Angew. Chem. Int. Ed. 1998, 37, 1986.
54. 1H NMR (estimated detection limits of 20:1) by comparison with authentic samples of each diastereomer.
55. Einhorn, J.; Einhorn, C.; Ratajczak, F.; Pierre, J.-L. J. Org. Chem. 1996, 61, 7452.
56. This isotopically labeled isoprostane could be used as an alternative standard for metabolic studies as shown in: Kim, S.; Powell, W. S.; Lawson, J. A.; Jacobo, S. H.; Pratico, D.; FitzGerald, G. A.; Maxey, K.; Rokach, J. Bioorg. Med. Chem. Lett. 2005, 15, 1613.
57. Williams, J. M.; Jobson, R. B.; Yasuda, N.; Marchesini, G.; Dolling, U.-J.; Grabowski, E. J. J. Tetrahedron Lett. 1995, 36, 5461.
58. For selected examples of GC/MS studies for the analysis of isoprostanes, see: (a) Roberts, L. J. II; Morrow, J. D. In Methods in Biological Oxidative Stress; Hensley, K.; Floyd, R. A., Eds.; Humana Press: Totawa NJ, 2003, Chap. 4, 33-39.
59. (b) Morrow, J. D.; Harris, T. M.; Roberts, L. J. II Anal. Biochem. 1990, 184, 1.
60. (c) Wang, Z.; Ciabattoni, G.; Creminon, C.; Lawson, J.; FitzGerald, G. A.; Patrono, C.; Maclouf, J. J. Pharmacol. Exp. Ther. 1995, 275, 94.
61. (d) Bachi, A.; Zuccato, E.; Baraldi, M.; Fanelli, R.; Chiabrando, C. Free Radic. Biol. Med. 1996, 20, 619.
62. (e) Waugh, R. J.; Murphy, R. C. J. Am. Soc. Mass Spectrom. 1996, 7, 490.
63. (f) Patrignani, P.; Santini, G.; Panara, M. R.; Sciulli, M.; Greco, A.; Rotondo, M. T.; diGiamberardino, M.; Maclouf, J.; Ciabattoni, G.; Patrono, C. Br. J. Pharmacol. 1996, 118, 1285.
64. More details on the setup and results of the GC/MS detection assay may be obtained by contacting the authors.
65. Garber, S. B.; Kingsbury, J. S.; Gray, B. L.; Hoveyda, A. H. J. Am. Chem. Soc. 2000, 122, 8168.
66. Theil, F.; Schick, H.; Winter, G.; Reck, G. Tetrahedron 1991, 47, 7569.
67. Data shown for a 74% yield reaction. Yields range from 70-90%, depending on catalyst purity.
68. This compound is the major isomer; however, it is in a mixture of isomers of lower deuterium incorporation.